UnknownPhase 3NCT02526953

Efficacy Study of Chemoradiotherapy With or Without Paclitaxel in Squamous-cell Anal Carcinoma Patients

Studying Squamous cell carcinoma of the rectum

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Blokhin's Russian Cancer Research Center
Principal Investigator
Arsen O Rasulov, PhD
N.N.Blokhin Russian Cancer Research Center
Intervention
Paclitaxel(drug)
Enrollment
314 target
Eligibility
18-70 years · All sexes
Timeline
2016 – 2022

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02526953 on ClinicalTrials.gov

Other trials for Squamous cell carcinoma of the rectum

Additional recruiting or active studies for the same condition.

See all trials for Squamous cell carcinoma of the rectum →

← Back to all trials